Clearside Biomedical, Inc. [NASDAQ: CLSD] stock went up by 9.56% or 0.28 points up from its previous closing price of $2.93. The stock reached $3.21 during the last trading session. During the course of the last 5 trading session in the week, CLSD share price went up during 2 out of 5 days, that way gaining +14.04% in the period of the last 7 days.
CLSD had two major price movements with the latest trading session as the price jumped to a high of $3.01, at one point touching $2.6533. The latest high is set lower that the high price recorded in the period of the last 52 weeks, set at $3.01. The 52-week high currently stands at $3.95 distance from the present share price, noting recovery 152.59% after the recent low of $0.56.
Clearside Biomedical, Inc. [NASDAQ:CLSD]: Analyst Rating and Earnings
Its stock price has been found in the range of 0.56 to 3.95. This is compared to its latest closing price of $2.93.
Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Tue 10 Mar (In 42 Days).
Fundamental Analysis of Clearside Biomedical, Inc. [CLSD]
Now let’s turn to look at profitability: with a current Operating Margin for Clearside Biomedical, Inc. [CLSD] sitting at -276483.33.
Turning to investigate this organization’s capital structure, Clearside Biomedical, Inc. [CLSD] has generated a Total Debt to Total Equity ratio of 42.23. Similarly, its Total Debt to Total Capital is 29.69, while its Total Debt to Total Assets stands at 22.61. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -78.47, and its Long-Term Debt to Total Capital is 39.88.
What about valuation? This company’s Enterprise Value to EBITDA is -0.59. The Enterprise Value to Sales for this firm is now 185.89, and its Total Debt to Enterprise Value stands at 5.03. Clearside Biomedical, Inc. [CLSD] has a Price to Book Ratio of 1.46.
Shifting the focus to workforce efficiency, Clearside Biomedical, Inc. [CLSD] earns $600 for each employee under its payroll. Similarly, this company’s Total Asset Turnover is 0.00. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 4.10 and its Current Ratio is 4.10. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Clearside Biomedical, Inc. [CLSD] has 40.16M shares outstanding, amounting to a total market cap of $117.67M. Its stock price has been found in the range of 0.56 to 3.95. At its current price, it has moved down by -18.73% from its 52-week high, and it has moved up 473.21% from its 52-week low.
This stock’s Beta value is currently 0.14, which indicates that it is 15.19% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 68.07. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Clearside Biomedical, Inc. [CLSD] a Reliable Buy?
Shares of Clearside Biomedical, Inc. [CLSD], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.